CAR-T cell therapies, dubbed ‘living drugs,’ involve extracting a patient’s T-cells, genetically modifying them to express Chimeric Antigen Receptors (CARs), specifically designed to recognise cancer cells and infusing them back into the patient.
Doctors Successfully Restored Vision In A 3-Year-Old With A Rare Cancer thehealthsite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehealthsite.com Daily Mail and Mail on Sunday newspapers.